[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H.R. 494 Introduced in House (IH)]
<DOC>
118th CONGRESS
1st Session
H. R. 494
To prohibit Federal funding to EcoHealth Alliance, Inc., and for other
purposes.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
January 25, 2023
Mr. Reschenthaler (for himself, Mr. Crawford, Mr. Posey, Mr. Baird, Mr.
DesJarlais, Mr. Crenshaw, Mr. Kelly of Pennsylvania, Mr. Mike Garcia of
California, Mr. Fitzpatrick, Mrs. Greene of Georgia, Mr. Gosar, Mr.
Duncan, Mr. Perry, Mr. Sessions, Mr. Jackson of Texas, Mr. Ogles, and
Mr. Guest) introduced the following bill; which was referred to the
Committee on Oversight and Accountability
_______________________________________________________________________
A BILL
To prohibit Federal funding to EcoHealth Alliance, Inc., and for other
purposes.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ``Defund EcoHealth Alliance Act''.
SEC. 2. PROHIBITION ON FEDERAL FUNDING TO ECOHEALTH ALLIANCE, INC.
(a) In General.--No funds authorized or appropriated by Federal law
may be made available for any purpose to EcoHealth Alliance, Inc.,
including any subsidiaries and related organizations that are directly
controlled by EcoHealth Alliance, Inc., including subgrant or
subcontract organizations or individuals.
(b) GAO Study and Report.--Not later than 2 years after the date of
the enactment of this Act, the Comptroller General of the United States
shall conduct a study, and submit a report to Congress, regarding the
amount of Federal funds awarded to EcoHealth Alliance, Inc. (directly
or indirectly through grants, contracts, subgrants, subcontracts, or
any other type of agreement or collaboration), during the 10-year
period preceding such date of enactment, that were provided, whether
purposely or inadvertently, to--
(1) the People's Republic of China;
(2) the Chinese Communist Party;
(3) the Wuhan Institute of Virology; or
(4) any other lab, agency, organization, individual, or
instrumentality--
(A) that is owned or controlled (directly or
indirectly) by any of the entities listed in paragraphs
(1) through (3); or
(B) located in any foreign nation.
<all>